Abbott Laboratories (ABT)
NYSE: ABT · IEX Real-Time Price · USD
102.03
+1.96 (1.96%)
At close: Jul 19, 2024, 4:02 PM
102.19
+0.16 (0.16%)
Pre-market: Jul 22, 2024, 5:26 AM EDT
Abbott Laboratories Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Abbott Laboratories stock have an average target of 122.3, with a low estimate of 107 and a high estimate of 140. The average target predicts an increase of 19.87% from the current stock price of 102.03.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ABT stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 1 | 3 | 3 | 3 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 9 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $125 → $120 | Buy | Maintains | $125 → $120 | +17.61% | Jul 2, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $125 | Buy | Reiterates | $125 | +22.51% | Jun 4, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $121 | Strong Buy | Initiates | $121 | +18.59% | May 30, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $128 → $119 | Strong Buy | Maintains | $128 → $119 | +16.63% | May 22, 2024 |
| Barclays | Barclays | Buy Maintains $141 → $140 | Buy | Maintains | $141 → $140 | +37.21% | Apr 22, 2024 |
Financial Forecast
Revenue This Year
42.16B
from 40.11B
Increased by 5.11%
Revenue Next Year
45.23B
from 42.16B
Increased by 7.28%
EPS This Year
4.67
from 3.26
Increased by 43.38%
EPS Next Year
5.19
from 4.67
Increased by 11.10%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 44.2B | 47.5B | 51.5B | 55.2B | 59.6B |
| Avg | 42.2B | 45.2B | 48.5B | 51.5B | 54.9B |
| Low | 40.6B | 43.4B | 46.1B | 48.2B | 50.9B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 10.2% | 12.8% | 13.8% | 13.7% | 15.9% |
| Avg | 5.1% | 7.3% | 7.3% | 6.0% | 6.8% |
| Low | 1.2% | 2.9% | 2.0% | -0.8% | -1.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 4.94 | 5.71 | 6.45 | 6.67 | 7.37 |
| Avg | 4.67 | 5.19 | 5.74 | 6.13 | 6.63 |
| Low | 4.48 | 4.93 | 5.39 | 5.55 | 5.86 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 51.4% | 22.2% | 24.2% | 16.1% | 20.2% |
| Avg | 43.4% | 11.1% | 10.6% | 6.7% | 8.2% |
| Low | 37.4% | 5.4% | 3.7% | -3.4% | -4.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.